comparemela.com
Home
Live Updates
Diabetes Dialogue: FLOW Trial and Semaglutides Benefit in Chronic Kidney Disease : comparemela.com
Diabetes Dialogue: FLOW Trial and Semaglutide's Benefit in Chronic Kidney Disease
Hosts break down the FLOW trial, take a deep dive into secondary findings, and provide insight into how this alters the perception of the role for semaglutide in management of CKD in type 2 diabetes.
Related Keywords
,
Natalie Bellini ,
Diana Isaacs ,
European Renal Association Congress ,
Training In Diabetes Technology ,
Diabetes Technology At University Hospitals ,
Metabolic Care Center ,
Hazard Ratio ,
Confidence Interval ,
Diabetes Technology ,
Endocrine Disorders ,
Cleveland Clinic ,
University Hospitals Diabetes ,
Diabetes Dialogue ,
comparemela.com © 2020. All Rights Reserved.